Prentiss Smith & Co’s Novo Nordisk NVO Stock Holding History

Prentiss Smith & Co’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-200	Closed	-$5K	–	173
2018 Q3	$5K	Hold	200	–	–	﹤0.01%	232
2018 Q2	$5K	Hold	200	–	–	﹤0.01%	237
2018 Q1	$5K	Sell	200 -1,260	-86%	-$33.1K	﹤0.01%	243
2017 Q4	$39K	Hold	1,460	–	–	0.02%	145
2017 Q3	$35K	Hold	1,460	–	–	0.02%	133
2017 Q2	$31K	Buy	1,460 +1,260	+630%	+$25.4K	0.02%	141
2017 Q1	$3K	Hold	200	–	–	﹤0.01%	223
2016 Q4	$4K	Hold	200	–	–	﹤0.01%	231
2016 Q3	$4K	Hold	200	–	–	﹤0.01%	226
2016 Q2	$5K	Hold	200	–	–	﹤0.01%	235
2016 Q1	$5K	Hold	200	–	–	﹤0.01%	266
2015 Q4	$6K	Hold	200	–	–	﹤0.01%	270
2015 Q3	$5K	Hold	200	–	–	﹤0.01%	261
2015 Q2	$5K	Hold	200	–	–	﹤0.01%	241
2015 Q1	$5K	Hold	200	–	–	﹤0.01%	264
2014 Q4	$4K	Buy	+200	New	+$4.47K	﹤0.01%	283

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Prentiss Smith & Co's NVO Position: Q4 2018 in Review

Prentiss Smith & Co sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 200 shares — an estimated $5K sold.

Prentiss Smith & Co first reported a position in NVO in Q4 2014 and held it in 16 quarters. The position peaked at $39K in Q4 2017. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

Prentiss Smith & Co reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
Prentiss Smith & Co sold 200 Novo Nordisk shares in Q4 2018, an estimated $5K.
Prentiss Smith & Co first reported a position in Novo Nordisk in Q4 2014 and held it in 16 quarters.
Prentiss Smith & Co's Novo Nordisk position peaked at $39K in Q4 2017.
550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on Prentiss Smith & Co's 13F filing for Q4 2018, filed 15 Jan 2019.